Systemic sclerosis (SSc), commonly known as scleroderma, is a rare, chronic autoimmune disease characterized by the thickening and hardening of the skin. This occurs when the body produces excessive amounts of collagen, a protein that normally provides strength and support to connective tissues. The excess collagen leads to a build-up of fibrous scar tissue, causing the skin to become tight, thick, and shiny.

The fingers and hands are among the most commonly affected areas. However, systemic sclerosis can also affect other parts of the body, including the face, arms, legs, and internal organs. When internal organs such as the lungs, kidneys, heart, or digestive system are involved, a person may experience additional symptoms and complications.

There are two main forms of systemic sclerosis: limited cutaneous systemic sclerosis and diffuse cutaneous systemic sclerosis.

• Limited systemic sclerosis: Skin thickening is generally restricted to areas below the elbows and knees, as well as the face and neck. The disease often progresses more gradually, although internal organs can still be affected.

• Diffuse systemic sclerosis: Skin thickening is more widespread and may extend above the elbows and knees to the upper arms, thighs, chest, and abdomen. This form has a greater risk of early internal organ involvement.

The severity and progression of systemic sclerosis vary from person to person. Early diagnosis, regular monitoring, and appropriate treatment are important for managing symptoms and reducing the risk of complications.

Systemic sclerosis is an autoimmune connective tissue disease. This means the body’s immune system mistakenly attacks healthy tissues, particularly the skin and connective tissues, rather than protecting the body from infections and other harmful substances.

The exact reason why the immune system behaves this way is not fully understood. However, this abnormal immune response can lead to inflammation, damage to small blood vessels, and excessive production of collagen, resulting in thickening and hardening of the skin and, in some cases, internal organs.

When the immune system is overactive, the body may experience ongoing inflammation, which can contribute to significant fatigue. Many people living with systemic sclerosis describe feeling extremely tired or drained, sometimes similar to the exhaustion experienced when fighting off the flu.

Fatigue can vary from person to person and may be influenced by disease activity, poor sleep, pain, and internal organ involvement.

Systemic sclerosis is a rare autoimmune disease that affects approximately 1 in every 100,000 people, although reported rates vary between populations and regions.

The disease is much more common in women than in men, with women accounting for approximately 75–90% of cases. It is most commonly diagnosed between the ages of 40 and 60, but it can develop at any age, including during childhood. Systemic sclerosis in children is particularly uncommon.

Diagnosing systemic sclerosis can be challenging, especially during the early stages of the disease. Initial symptoms may be subtle or resemble those of other conditions. Symptoms such as Raynaud’s phenomenon, swollen fingers, joint pain, and fatigue may appear before more noticeable skin changes develop.

Early recognition and diagnosis are important because they allow for appropriate monitoring, treatment, and early detection of possible complications affecting internal organs.

Types of Systemic Sclerosis

Systemic sclerosis, also known as scleroderma, can cause a wide range of symptoms depending on the type of disease and the areas of the body affected.

There are two main forms of systemic sclerosis: limited cutaneous systemic sclerosis and diffuse cutaneous systemic sclerosis.

1. Limited Cutaneous Systemic Sclerosis

In limited systemic sclerosis, skin thickening is generally restricted to the lower parts of the arms (below the elbows), the lower legs (below the knees), and the face and neck. In many people, the most noticeable skin changes occur on the fingers, face, and neck.

Symptoms may develop gradually over many years. People with this form often experience Raynaud’s phenomenon for several years before other signs of systemic sclerosis become apparent.

Although skin involvement is more limited, internal organs can still be affected. Some people may develop complications involving the lungs, digestive system, or blood vessels.

2. Diffuse Cutaneous Systemic Sclerosis

Diffuse systemic sclerosis involves more widespread skin thickening and can affect areas beyond the elbows and knees, including the upper arms, thighs, chest, abdomen, and back.

This form often develops more rapidly than the limited form. Early symptoms may include sudden swelling, tightness, and soreness in the hands and fingers, along with Raynaud’s phenomenon.

Diffuse systemic sclerosis has a greater risk of early internal organ involvement, particularly affecting the lungs, heart, kidneys, and digestive system. Early diagnosis and regular medical monitoring are especially important.

As systemic sclerosis progresses, the skin can become thickened, tight, and shiny due to the buildup of excess collagen and fibrous tissue. These changes can affect the skin’s appearance, texture, and flexibility.

Skin pigmentation may also change. Some areas may lose their natural colour, while others become darker. This can create a distinctive “salt and pepper” appearance, where lighter and darker patches of skin appear together.

When the skin on the face becomes tight, normal facial wrinkles may become less noticeable or disappear. Tightening around the mouth can cause the mouth opening to become smaller, making everyday activities such as eating, brushing teeth, and dental care more difficult.

The layer of fat beneath the skin may also become thinner or disappear in some areas. This can cause the cheeks to appear hollow and change the overall shape and appearance of the face.

These skin changes can vary from person to person and may develop gradually or progress more rapidly, depending on the type of systemic sclerosis.

Systemic sclerosis (SSc), also known as scleroderma, can affect much more than the skin. Because it is a connective tissue disease, it can involve several internal organs and body systems. The type and severity of symptoms vary from person to person.

Some people experience mostly skin and circulation problems, while others may develop complications involving the lungs, kidneys, digestive system, heart, joints, and muscles.

Lung Involvement

Systemic sclerosis can affect the lungs and cause two major types of complications:

1. Pulmonary Fibrosis (Lung Scarring)

Systemic sclerosis can cause inflammation and scarring of the lung tissue, a condition known as interstitial lung disease (ILD). As scar tissue builds up, the lungs become stiffer and have difficulty expanding properly, making it harder for oxygen to move into the bloodstream.

Symptoms may include:

• Shortness of breath, especially during physical activity.

• A persistent dry cough.

• Reduced ability to exercise.

• Fatigue and decreased stamina.

2. Pulmonary Hypertension (High Blood Pressure in the Lungs)

Systemic sclerosis can also damage and narrow the blood vessels that carry blood through the lungs. This can lead to pulmonary hypertension, which is abnormally high blood pressure in the arteries of the lungs.

As the pressure increases, the right side of the heart must work harder to pump blood through the lungs. Over time, this can cause strain on the heart and potentially lead to heart failure.

Symptoms may include shortness of breath, chest discomfort, dizziness, and swelling in the legs or ankles.

Regular screening and monitoring are important because lung complications may develop before noticeable symptoms appear.

Kidney Involvement and High Blood Pressure

Systemic sclerosis can affect the kidneys by damaging the small blood vessels that supply them with blood. One of the most serious complications is called scleroderma renal crisis.

This condition occurs when blood pressure rises suddenly and dramatically, potentially causing rapid kidney damage. It is a medical emergency that requires immediate treatment.

People with systemic sclerosis, particularly those with the diffuse form, should have their blood pressure monitored regularly. Sudden increases in blood pressure, severe headaches, vision changes, or reduced urine output require urgent medical assessment.

Early recognition and treatment are essential to protect kidney function.

Digestive Problems: Swallowing Difficulties, Heartburn, and Bloating

Systemic sclerosis can affect the digestive system, particularly the esophagus, which is the tube that carries food from the mouth to the stomach.

When the muscles of the esophagus become weakened or do not function properly, food may move more slowly toward the stomach. This can cause:

• Difficulty swallowing food or liquids.

• A sensation that food is getting stuck in the throat or chest.

• Increased risk of choking or food entering the airway.

• Acid reflux and frequent heartburn.

Systemic sclerosis can also affect the stomach and intestines, making it more difficult to digest food and absorb nutrients. In some cases, this can lead to weight loss and malnutrition.

Another possible complication is small intestinal bacterial overgrowth (SIBO). This occurs when excessive bacteria accumulate in the small intestine and may cause:

• Abdominal bloating and discomfort.

• Excessive gas.

• Constipation.

• Diarrhea, which may be severe or have an unpleasant smell.

• Difficulty absorbing nutrients.

When SIBO is suspected, healthcare providers may recommend testing and treatment, which can include antibiotics.

Raynaud’s Phenomenon (Colour Changes in the Fingers and Toes)

Almost everyone with systemic sclerosis experiences Raynaud’s phenomenon. This condition causes the small blood vessels in the fingers and toes to overreact to cold temperatures or emotional stress.

The blood vessels suddenly narrow, reducing blood flow to the affected areas. The fingers and toes may turn white, then blue, and sometimes red as circulation returns.

Other symptoms may include numbness, tingling, pain, and burning sensations.

Raynaud’s phenomenon often develops differently depending on the type of systemic sclerosis:

• Limited systemic sclerosis: Raynaud’s phenomenon may begin several years before noticeable skin changes develop.

• Diffuse systemic sclerosis: Raynaud’s phenomenon often appears around the same time as the initial skin symptoms.

Raynaud’s associated with systemic sclerosis can be more severe than Raynaud’s occurring on its own. Reduced blood flow can sometimes cause painful sores or ulcers on the fingertips. In severe cases, tissue damage can occur.

Protecting the hands and feet from cold temperatures and seeking medical treatment for persistent circulation problems are important.

Telangiectasia (Small Red Spots on the Skin)

Telangiectasia are small, widened blood vessels that appear as tiny red spots or lines on the skin.

In systemic sclerosis, these changes occur when small blood vessels become damaged or enlarged. They commonly appear on:

• The palms of the hands.

• The fingers.

• The face.

• Around the mouth and lips.

Although telangiectasia are generally harmless on their own, they are a common skin feature of systemic sclerosis.

Fatigue

Fatigue is a common symptom of systemic sclerosis and can significantly affect everyday life.

The abnormal immune response and ongoing inflammation associated with the disease can contribute to persistent tiredness and a feeling of exhaustion, sometimes similar to the fatigue experienced when fighting a viral infection.

Fatigue may also be influenced by joint pain, poor sleep, digestive problems, anemia, and internal organ involvement.

Some people experience fatigue even when their other symptoms appear to be under control.

Joint and Tendon Inflammation

Systemic sclerosis can affect the joints, muscles, and tendons, causing inflammation, stiffness, and pain.

Some people develop inflammatory arthritis, which can cause swollen, tender, and painful joints. The fingers may become particularly swollen, sometimes taking on a sausage-like appearance.

Tendons can also become inflamed or thickened, making movement uncomfortable and reducing flexibility.

These symptoms may interfere with everyday activities such as gripping objects, opening containers, and performing tasks that require fine finger movements.

Carpal Tunnel Syndrome (Numbness and Tingling in the Fingers)

Carpal tunnel syndrome can occur in people with systemic sclerosis, particularly during the early stages of the disease.

Swelling and inflammation around the wrist can put pressure on the median nerve, which passes through a narrow space called the carpal tunnel.

This compression can cause:

• Numbness or tingling in the fingers.

• Pain in the wrist or hand.

• Burning sensations.

• Weakness or difficulty gripping objects.

Symptoms may be more noticeable at night or when using the hands for extended periods.

Other Symptoms and Associated Conditions

Some people with systemic sclerosis may also experience symptoms associated with other autoimmune connective tissue diseases. This is sometimes referred to as an overlap syndrome.

Additional symptoms may include:

• Dry eyes and dry mouth: Reduced moisture production can cause irritation, discomfort, and difficulty swallowing.

• Muscle inflammation (myositis): Inflammation of the muscles can cause muscle pain and weakness, particularly in the shoulders, upper arms, hips, and thighs.

• Muscle weakness: Some people may have difficulty climbing stairs, lifting objects, or getting up from a seated position.

These additional symptoms may require further investigation and specialized treatment.

The Importance of Regular Monitoring

Systemic sclerosis is a complex disease that can affect multiple organs, sometimes without causing obvious symptoms in the early stages. Regular follow-up with a rheumatologist and other specialists is important to monitor disease activity and identify complications as early as possible.

Monitoring may include lung function testing, heart assessments, kidney function tests, blood pressure checks, and evaluation of digestive symptoms.

Early recognition, appropriate treatment, and ongoing medical care can help reduce complications, protect organ function, and improve quality of life for people living with systemic sclerosis.

Systemic sclerosis is best diagnosed by a rheumatologist, a medical specialist who focuses on arthritis, autoimmune diseases, and conditions affecting the joints, muscles, and connective tissues.

Diagnosing systemic sclerosis can be challenging, particularly during the early stages, because symptoms may develop gradually and can resemble those of other medical conditions.

To determine whether someone has systemic sclerosis, the doctor will take a detailed medical history and perform a thorough physical examination. They will ask about symptoms such as Raynaud’s phenomenon, skin thickening, swollen fingers, joint pain, fatigue, and digestive problems.

The doctor will also examine the skin, hands, fingers, and other affected areas for signs of skin thickening, changes in circulation, and other characteristic features of the disease.

Based on the findings, the rheumatologist may recommend additional investigations, including blood tests, imaging studies, and specialized assessments of internal organ function.

Common Tests Used to Diagnose Systemic Sclerosis

There is no single test that can independently confirm systemic sclerosis. Instead, the diagnosis is based on a combination of symptoms, physical examination findings, blood test results, and other investigations.

Some commonly used tests include:

• Blood tests: Help identify specific autoantibodies associated with systemic sclerosis and assess for other signs of autoimmune disease.

• Antinuclear antibody (ANA) testing: Looks for antibodies that may indicate an abnormal immune response. Most people with systemic sclerosis have a positive ANA test.

• Specific autoantibody testing: Tests for antibodies such as anticentromere, anti-Scl-70 (topoisomerase I), and anti-RNA polymerase III, which can help support the diagnosis and identify disease patterns.

• Nailfold capillaroscopy: Examines the tiny blood vessels around the fingernails for changes commonly associated with systemic sclerosis.

• Pulmonary function tests: Assess how well the lungs are working and help identify possible lung involvement.

• High-resolution CT scan: May be used to look for inflammation or scarring in the lungs.

• Echocardiogram: Evaluates heart function and helps screen for pulmonary hypertension.

• Kidney function tests: Assess kidney health and help identify potential complications.

The rheumatologist will interpret the results together rather than relying on any one test to make the diagnosis.

Early diagnosis is important because systemic sclerosis can affect internal organs even when symptoms are mild or not yet noticeable. Identifying the disease early allows for appropriate treatment, regular monitoring, and earlier detection of potential complications.

The exact cause of systemic sclerosis (SSc), also known as scleroderma, is not fully understood. However, scientists believe it develops through a combination of immune system abnormalities, genetic factors, and environmental influences.

Systemic sclerosis is an autoimmune connective tissue disease. This means the body’s immune system mistakenly identifies healthy tissues as harmful and begins attacking them, particularly the skin and connective tissues.

This abnormal immune response can cause inflammation and damage to small blood vessels while stimulating the body to produce excessive amounts of collagen. Collagen is a protein that normally provides strength and structure to the skin and connective tissues.

When too much collagen builds up, it forms thick, fibrous scar tissue, causing the skin and affected tissues to become hardened, tight, and less flexible. This process is known as fibrosis.

In some people, this process can also affect internal organs, including the lungs, heart, kidneys, and digestive system.

The extent of tissue and organ involvement varies from person to person.

Preventive Strategies

Preventive care is an important part of managing systemic sclerosis. Taking steps to protect the skin, circulation, and internal organs can help reduce complications.

Some helpful strategies include:

• Keeping the hands and feet warm to reduce Raynaud’s attacks.

• Avoiding smoking, as it can worsen circulation.

• Protecting the skin from cuts, injuries, and excessive dryness.

• Maintaining regular medical appointments and recommended screening tests.

• Monitoring blood pressure regularly, particularly in people with diffuse systemic sclerosis.

• Reporting new symptoms, such as shortness of breath, difficulty swallowing, or fingertip ulcers, to a healthcare provider.

• Following a balanced diet and maintaining appropriate physical activity.

Managing Fatigue

Fatigue is one of the most common symptoms experienced by people living with systemic sclerosis. Unfortunately, it can also be one of the most difficult symptoms to manage.

People may experience persistent exhaustion even when they have had enough sleep or are not particularly physically active. Fatigue may be related to inflammation, pain, poor sleep, anemia, digestive problems, or internal organ involvement.

Learning to balance daily activities with the body’s need for rest is an important part of managing fatigue.

Helpful strategies include:

• Pacing activities: Break larger tasks into smaller, more manageable steps.

• Prioritizing responsibilities: Focus on essential activities and avoid trying to accomplish everything in one day.

• Scheduling rest periods: Take regular breaks throughout the day, especially after physically demanding activities.

• Maintaining gentle exercise: Appropriate physical activity can help improve stamina and overall well-being.

• Getting adequate sleep: Establish a consistent sleep routine and address problems that interfere with restful sleep.

• Accepting support: Ask family members, friends, or caregivers for help when needed.

It is also important to discuss persistent or worsening fatigue with a healthcare provider, as treatable conditions may be contributing to it.

The Importance of Individualized Care

Systemic sclerosis is a complex disease that requires ongoing medical care and monitoring. Treatment may involve a rheumatologist, physiotherapist, occupational therapist, dermatologist, cardiologist, pulmonologist, and other specialists depending on the organs affected.

The overall goal of treatment is to manage symptoms, prevent complications, preserve mobility and independence, protect internal organs, and help people living with systemic sclerosis maintain the best possible quality of life.

Medications for Raynaud’s Phenomenon

Raynaud’s phenomenon is a common feature of systemic sclerosis that occurs when the small blood vessels in the fingers and toes narrow in response to cold temperatures or stress. This reduces blood flow to the affected areas, causing changes in skin colour, numbness, tingling, and sometimes pain.

Medications that relax and widen the blood vessels (known as vasodilators) can help improve circulation. These medications may reduce the frequency and severity of Raynaud’s attacks and help prevent complications caused by poor blood flow.

Several types of medications may be used to manage Raynaud’s phenomenon.

1. Calcium Channel Blockers

Calcium channel blockers are commonly used as an initial treatment for Raynaud’s phenomenon. They work by relaxing the muscles in the walls of blood vessels, allowing them to widen and improve blood flow.

Examples include:

• Nifedipine.

• Amlodipine.

• Felodipine.

These medications may also help lower blood pressure.

2. Medications That Improve Blood Flow (PDE-5 Inhibitors)

Medications such as sildenafil (Viagra) and tadalafil (Cialis) may be prescribed for people with more severe Raynaud’s symptoms.

These medications work by relaxing the smooth muscles in blood vessel walls, helping blood vessels widen and improving circulation to the fingers and toes.

They may be particularly helpful when Raynaud’s phenomenon causes persistent symptoms or painful fingertip ulcers.

3. Other Vasodilator Medications

Other medications that relax and widen blood vessels may be considered when initial treatments do not provide sufficient relief.

These medications can improve circulation but may also cause side effects such as low blood pressure, dizziness, and light-headedness.

4. Topical Nitrate Treatments

Topical nitrates are medications applied directly to the skin, often in the affected areas of the fingers.

They work by relaxing blood vessels and increasing local blood flow. They may be considered for people who experience symptoms in specific fingers or areas.

However, topical nitrates can cause headaches, dizziness, and low blood pressure. They must not be combined with PDE-5 inhibitors such as sildenafil or tadalafil because the combination can cause a dangerous drop in blood pressure.

5. Intravenous Iloprost

For people with severe Raynaud’s phenomenon, particularly when painful fingertip ulcers or threatened tissue damage develop, intravenous iloprost may be recommended.

Iloprost is a medication that helps widen blood vessels and improve circulation. It can be particularly effective in treating severe circulation problems and helping existing fingertip ulcers heal.

It is administered through an intravenous infusion under medical supervision, usually in a hospital or specialized treatment setting.

The Importance of Individualized Treatment

The treatment of Raynaud’s phenomenon in systemic sclerosis depends on the severity of symptoms, the degree of circulation problems, and whether complications such as fingertip ulcers are present.

Some people respond well to simple medications, while others may require more specialized treatments.

Regular follow-up with a rheumatologist is important to monitor treatment effectiveness, manage side effects, and protect circulation in the fingers and toes.

The main goals of treatment are to improve blood flow, reduce Raynaud’s attacks, relieve pain, prevent fingertip ulcers, and protect the affected tissues from damage.

Ankylosing spondylitis (AS) should be diagnosed early and managed effectively to control inflammation, maintain spinal flexibility, and preserve joint mobility. Early treatment can help slow disease progression and reduce the risk of long-term complications, including the fusion of bones in the spine.

Although existing structural damage caused by AS cannot usually be reversed with medication, appropriate treatment can help relieve pain, reduce inflammation, improve mobility, and preserve physical function. Regular follow-up appointments with a rheumatologist are essential, along with completing any recommended blood tests and imaging scans to monitor disease activity and assess treatment effectiveness.

The management of ankylosing spondylitis generally involves two key approaches:

• Physical therapy and exercise: Regular physical activity, physiotherapy, and daily stretching can help reduce stiffness, maintain flexibility, improve posture, and support overall mobility.
• Medication: Medications can help control inflammation, relieve pain, and improve physical function and quality of life.

A summary of the main treatment options available to help manage ankylosing spondylitis and improve patients’ quality of life is provided below.

Almost everyone living with systemic sclerosis experiences a condition called Raynaud’s phenomenon. This occurs when the small blood vessels in the fingers and toes overreact to cold temperatures or emotional stress, causing them to temporarily narrow and reduce blood flow.

During an episode, the fingers and toes may change colour, typically turning white as blood flow decreases, then blue as oxygen levels in the affected tissues drop, and finally red as blood flow returns. Not everyone experiences all three colour changes.

Other symptoms may include numbness, tingling, pain, or a burning sensation in the affected areas.

Raynaud’s phenomenon can be triggered by exposure to cold weather, handling cold objects, or sudden temperature changes. Keeping the hands and feet warm, avoiding sudden exposure to cold, and managing stress can help reduce episodes.

In people with systemic sclerosis, Raynaud’s phenomenon can sometimes be more severe and may lead to painful fingertip ulcers or tissue damage due to reduced circulation. Regular medical monitoring and appropriate treatment are important to help protect the fingers and toes.

Early diagnosis and treatment of Systemic Sclerosis (Scleroderma) Education are essential to help manage the condition and slow its progression.

Appropriate treatment can reduce inflammation, relieve pain and stiffness, maintain mobility, and help prevent long-term complications, including damage to the spine. Effective management may also help reduce the risk of complications associated with chronic inflammation, such as cardiovascular disease, and support overall health and well-being.

There is no specific diet proven to stop AS or reverse spinal changes. A Mediterranean-style pattern—vegetables and fruit, whole grains, legumes, nuts, fish, and unsaturated fats—is a reasonable approach for overall health. Foods such as tomatoes and bell peppers can be included, but they shouldn’t be considered treatments for AS.

Tomatoes and Systemic Sclerosis (Scleroderma) Education

Tomatoes can be a nutritious addition to an arthritis-friendly diet, although they do not cure Systemic Sclerosis (Scleroderma) Education or directly reverse joint damage.

• Lycopene: Tomatoes are particularly rich in lycopene, an antioxidant that helps protect cells from oxidative stress. Cooked tomatoes and tomato products can provide especially well-absorbed lycopene.

• Vitamin C: Supports collagen formation and normal connective-tissue function.

• Antioxidants: Tomatoes contain vitamin C, carotenoids, and other plant compounds that contribute to overall antioxidant intake.

• Potential anti-inflammatory effects: Laboratory and observational research suggests that compounds in tomatoes may influence inflammatory pathways, but evidence that eating tomatoes significantly reduces arthritis pain or inflammation in people is still limited.

• Heart health: Tomatoes can contribute to a heart-healthy diet, which is particularly relevant for people with Systemic Sclerosis (Scleroderma) Education, because RA is associated with increased cardiovascular risk.

Some people with Systemic Sclerosis (Scleroderma) Education report that tomatoes or other nightshade vegetables worsen their symptoms. There isn’t strong scientific evidence that tomatoes generally cause Systemic Sclerosis (Scleroderma) Education inflammation or should routinely be avoided. If you consistently notice symptoms after eating a particular food, discussing this pattern with a healthcare professional or dietitian can be more useful than eliminating foods unnecessarily.

For Systemic Sclerosis (Scleroderma) Education, tomatoes are best viewed as part of an overall nutritious eating pattern. For rheumatoid arthritis, diet can complement medical treatment but shouldn’t replace disease-modifying medication when it is prescribed.

Physical and Occupational Therapy

Physical and occupational therapy play an important role in managing systemic sclerosis, particularly when the hands, fingers, joints, and muscles are affected.

Skin tightening and joint stiffness can make everyday activities more difficult. Exercises and supportive therapies can help maintain flexibility, improve mobility, and preserve hand function.

Treatment strategies may include:

• Range-of-motion exercises: Gentle stretching exercises help maintain movement and flexibility in the fingers, hands, wrists, and other affected joints.

• Physical therapy: Helps maintain muscle strength, mobility, balance, and overall physical function.

• Occupational therapy: Helps people develop strategies to manage everyday activities, such as dressing, cooking, writing, and personal care.

• Assistive devices: Specially designed tools and aids can make daily tasks easier and reduce strain on affected joints.

• Splints and supports: May help maintain joint positioning, support hand function, and improve comfort when appropriate.

Regular movement and appropriate exercises can help reduce stiffness and maintain independence.

Living with Systemic Sclerosis (Scleroderma) Education can affect mental health in several ways. Research consistently shows that people with AS have higher rates of anxiety and depression than the general population, although not everyone with Systemic Sclerosis (Scleroderma) Education experiences these challenges.

Some of the reasons include:

• Chronic pain: Ongoing pain can increase stress, irritability, and emotional exhaustion.
• Fatigue: Persistent fatigue can make it harder to work, socialize, or enjoy activities, contributing to low mood.
• Sleep disruption: Pain and stiffness often interfere with sleep, which can worsen anxiety and depression.
• Reduced mobility: Difficulty with movement or physical limitations may lead to frustration or loss of independence.
• Uncertainty about the future: Concerns about disease progression, work, or relationships can increase emotional distress.
• Inflammation: Some evidence suggests that inflammation itself may contribute to changes in mood, although this relationship is still being studied.

Systemic sclerosis (SSc), also known as scleroderma, can affect several parts of the digestive system, joints, and internal organs. Medications are selected based on the symptoms a person experiences and the extent of organ involvement.

Treatment is individualized, with the goals of relieving symptoms, improving daily function, reducing inflammation, and preventing or slowing complications.

1. Medications for Heartburn, Acid Reflux, and Digestive Problems

Digestive problems are common in people with systemic sclerosis because the disease can affect the muscles and nerves responsible for moving food through the digestive tract.

Proton Pump Inhibitors (PPIs)

Proton pump inhibitors (PPIs) are commonly prescribed to manage heartburn and acid reflux.

These medications work by reducing the amount of acid produced by the stomach, helping to relieve symptoms such as:

• Heartburn and acid reflux.

• Burning sensations in the chest or upper abdomen.

• Irritation of the esophagus (swallowing tube).

• Acid-related indigestion and stomach discomfort.

Reducing stomach acid can also help protect the esophagus from damage caused by repeated acid exposure.

Medications That Improve Digestive Movement (Prokinetic Agents)

Systemic sclerosis can affect the muscles of the esophagus, stomach, and intestines, slowing the movement of food through the digestive tract.

Medications called prokinetic agents help stimulate muscle contractions and improve the movement of food through the digestive system.

Examples include:

• Domperidone.

• Prucalopride.

• Erythromycin.

These medications may help with symptoms such as delayed stomach emptying, bloating, nausea, and early fullness. Some may also help reduce reflux symptoms by improving digestive movement.

The choice of medication depends on which part of the digestive tract is affected.

Treatment for Swallowing Difficulties

Some people with systemic sclerosis experience difficulty swallowing because the muscles of the esophagus become weakened or do not move food properly.

Food may feel as though it is getting stuck behind the breastbone or moving slowly down the swallowing tube.

Domperidone may sometimes be considered to help improve digestive movement, depending on the underlying problem.

In certain cases, a procedure called esophageal dilation may be recommended. This procedure involves gently stretching or widening a narrowed area of the esophagus to help food pass through more easily.

Antibiotics for Small Intestinal Bacterial Overgrowth (SIBO)

Some people with systemic sclerosis develop small intestinal bacterial overgrowth (SIBO). This occurs when excessive bacteria accumulate in the small intestine, often because normal digestive movement has slowed down.

Symptoms may include:

• Abdominal bloating and discomfort.

• Excessive gas.

• Feeling full after eating small amounts.

• Diarrhea or changes in bowel habits.

• Difficulty absorbing nutrients.

Antibiotics may be prescribed to reduce the excessive bacterial growth and improve digestive symptoms.

It is important to understand that antibiotics treat the bacterial overgrowth, not systemic sclerosis itself. Symptoms may return, and some people require further treatment.

Managing Weight Loss and Nutritional Problems

People with systemic sclerosis may experience early fullness, difficulty swallowing, poor digestion, or reduced nutrient absorption. These problems can lead to unintended weight loss and malnutrition.

If someone is losing weight without trying or struggling to eat enough, they should speak with their healthcare provider.

Helpful strategies may include:

• Eating smaller, more frequent meals throughout the day.

• Choosing foods that are easy to swallow and digest.

• Increasing calorie and protein intake when needed.

• Using high-calorie or high-protein nutritional drinks or supplements.

• Working with a registered dietitian to address nutritional needs.

Maintaining adequate nutrition is particularly important for overall health, strength, and recovery.

2. Medications for Swollen and Inflamed Joints

Systemic sclerosis can cause joint pain, swelling, stiffness, and inflammation. Some people develop inflammatory arthritis, which can interfere with movement and everyday activities.

Medications similar to those used to treat rheumatoid arthritis may be considered, depending on the severity of joint involvement.

These include:

• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Help reduce joint pain, swelling, and inflammation.

• Analgesics (Pain Relievers): Help manage pain but do not treat the underlying inflammation.

• Corticosteroids (Prednisone): Reduce inflammation and may be used in selected situations.

• Disease-Modifying Anti-Rheumatic Drugs (DMARDs): Medications such as methotrexate or hydroxychloroquine may help control inflammatory joint symptoms.

Treatment choices need to be carefully considered by a rheumatologist. In particular, corticosteroids such as prednisone should be used cautiously in systemic sclerosis because higher doses are associated with an increased risk of scleroderma renal crisis.

3. Medications for Severe Systemic Sclerosis With Internal Organ Involvement (Immunosuppressants)

When systemic sclerosis affects internal organs such as the lungs, kidneys, or heart, more specialized treatment may be necessary.

Immunosuppressive medications work by reducing abnormal immune system activity and inflammation. They may help control disease activity and prevent further damage in certain forms of organ involvement.

Examples include:

• Mycophenolate mofetil (CellCept): Commonly used to treat systemic sclerosis-associated interstitial lung disease and skin involvement.

• Cyclophosphamide (Cytoxan): A stronger immunosuppressive medication that may be used in selected cases of significant organ involvement.

• Methotrexate: May be used for certain skin and joint symptoms.

• Rituximab (Rituxan): A biologic medication that targets specific immune cells and may be considered in selected patients.

• Tocilizumab (Actemra): A biologic medication that targets inflammation and may be considered in certain people with early diffuse systemic sclerosis, particularly when lung involvement is present.

The choice of treatment depends on which organs are affected, the severity of the disease, and the individual’s overall health.

Different organ complications may require different medications. For example, pulmonary hypertension requires specialized medications that improve blood flow through the lungs, while scleroderma renal crisis requires urgent blood pressure treatment, usually with an ACE inhibitor.

The Importance of Individualized Treatment

There is currently no cure for systemic sclerosis, but many treatments are available to manage symptoms, protect organ function, and improve quality of life.

Because the disease affects everyone differently, treatment plans should be developed with a rheumatologist and other specialists as needed.

Regular monitoring is essential to assess how well medications are working, identify potential side effects, and detect new organ complications.

The overall goal of treatment is to control symptoms, reduce disease complications, preserve organ function, and help people living with systemic sclerosis maintain their independence and quality of life.

Blood tests are an important part of investigating and monitoring systemic sclerosis (SSc). They can help doctors identify inflammation, detect specific autoantibodies, and assess whether organs such as the kidneys or muscles may be affected.

Some of the commonly ordered blood tests include:

1. Looking for Inflammation

Doctors may order blood tests to look for signs of inflammation and assess overall blood cell health.

• Complete Blood Count (CBC): Measures the levels of red blood cells, white blood cells, and platelets. It can help identify anemia, changes in white blood cell counts, and other abnormalities.

• Erythrocyte Sedimentation Rate (ESR): Measures how quickly red blood cells settle in a test tube. A faster-than-normal rate may indicate inflammation somewhere in the body.

• C-Reactive Protein (CRP): Measures a protein produced by the liver in response to inflammation. Elevated levels may suggest an inflammatory process.

These tests can provide useful information about inflammation, although normal results do not rule out systemic sclerosis.

2. Looking for Autoantibodies (ANA Test)

Most people with systemic sclerosis have a positive Antinuclear Antibody (ANA) test.

This blood test looks for antibodies that mistakenly recognize and react against components of the body’s own cells. These antibodies are called autoantibodies.

The ANA test can help identify an abnormal immune response and provide clues that an autoimmune disease may be present.

The pattern seen under the microscope during ANA testing can also provide useful information. Certain patterns are associated with different types of systemic sclerosis and may help guide further testing.

However, a positive ANA result alone does not confirm systemic sclerosis. Additional antibody testing and clinical findings are needed to establish the diagnosis.

3. Looking for Specific Autoantibodies (ENA Panel)

The Extractable Nuclear Antigen (ENA) Panel is a blood test that looks for antibodies directed against specific proteins in the body’s cells.

In people suspected of having systemic sclerosis, doctors may look for several important antibodies, including:

• Anticentromere antibodies: Commonly associated with limited cutaneous systemic sclerosis.

• Anti-Scl-70 (topoisomerase I) antibodies: More commonly associated with diffuse disease and an increased risk of lung involvement.

• Anti-RNA polymerase III antibodies: Associated with diffuse systemic sclerosis and an increased risk of scleroderma renal crisis.

Other antibodies may also be tested depending on the person’s symptoms and suspected disease features.

These results can help support the diagnosis, identify disease patterns, and assess the potential risk of certain complications.

4. Looking at Kidney Function (Creatinine)

Creatinine is a waste product produced by normal muscle activity and removed from the bloodstream by the kidneys.

A creatinine blood test helps doctors evaluate how well the kidneys are filtering waste products from the blood.

Higher-than-normal creatinine levels may indicate reduced kidney function or kidney damage. In people with systemic sclerosis, this is particularly important because the disease can affect the small blood vessels supplying the kidneys.

Regular kidney function testing, together with blood pressure monitoring, can help identify potential kidney complications early.

5. Looking at Muscle Enzymes (Creatine Kinase or CK)

The Creatine Kinase (CK) blood test measures an enzyme found mainly in skeletal muscles, the heart, and the brain.

When muscle tissue becomes inflamed or damaged, CK can leak from muscle cells into the bloodstream, causing blood levels to rise.

Elevated CK levels may indicate muscle inflammation or injury, including a condition called myositis, which can sometimes occur alongside systemic sclerosis.

Doctors may order this test when someone experiences muscle pain, tenderness, or weakness.

Additional testing may be needed to determine the cause of an elevated CK level.

Why are these blood tests important?

Together, these tests help rheumatologists build a clearer picture of the disease. They can provide information about immune system activity, inflammation, kidney function, and possible muscle involvement.

It is important to remember that no single blood test can diagnose systemic sclerosis on its own. Results must be interpreted alongside a person’s symptoms, physical examination, and other diagnostic investigations.